Monday, August 25th, 2025
Stock Profile: NSPR
NSPR Logo

InspireMD, Inc. (NSPR)

Market: NASD | Currency: USD

Address: 4 Menorat Hamaor Street

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute Show more




📈 InspireMD, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2021 - $0.066667 - 2021-04-27 - Stock split
Total Amount for 2021: $0.066667
2019 - $0.020000 - 2019-04-01 - Stock split
Total Amount for 2019: $0.020000
2016 - $0.040000 - 2016-10-10 - Stock split
Total Amount for 2016: $0.040000
2015 - $0.100000 - 2015-10-01 - Stock split
Total Amount for 2015: $0.100000


📅 Earnings & EPS History for InspireMD, Inc.


DateReported EPS
2025-11-12 (estimated upcoming)-
2025-08-04-0.26
2025-05-08-0.22
2025-03-12-0.18
2024-11-12-0.16
2024-08-05-0.22
2024-05-13-0.21
2024-03-05-0.13
2023-11-06-0.15
2023-08-07-0.24
2023-05-15-0.53
2023-03-30-0.6
2022-11-07-0.58
2022-08-08-0.59
2022-05-09-0.57
2022-03-07-0.53
2021-11-08-0.53
2021-08-09-0.46
2021-05-10-0.53
2021-03-08-1.2
2020-11-09-0.9
2020-08-05-3
2020-05-11-6.45
2020-03-10-8.55
2019-11-12-18.9




📰 Related News & Research


No related articles found for "inspiremd inc".